Aequus Pharmaceuticals Financials
| AQSZF Stock | USD 0.01 0 18.18% |
With this module, you can analyze Aequus financials for your investing period. You should be able to track the changes in Aequus Pharmaceuticals individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Aequus |
Understanding current and past Aequus Pharmaceuticals Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Aequus Pharmaceuticals' financial statements are interrelated, with each one affecting the others. For example, an increase in Aequus Pharmaceuticals' assets may result in an increase in income on the income statement.
The data published in Aequus Pharmaceuticals' official financial statements typically reflect Aequus Pharmaceuticals' business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Aequus Pharmaceuticals' quantitative information. For example, before you start analyzing numbers published by Aequus accountants, it's essential to understand Aequus Pharmaceuticals' liquidity, profitability, and earnings quality within the context of the Pharmaceuticals space in which it operates.
Aequus Pharmaceuticals Stock Summary
Aequus Pharmaceuticals competes with Grey Cloak. Aequus Pharmaceuticals Inc., a specialty pharmaceutical company, develops and commercializes drugs in Canada. Aequus Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada. Aequus Pharmaceuticals operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 14 people.| Instrument | USA OTC Stock View All |
| Exchange | OTCQB Exchange |
| Business Address | 200 Granville Street, |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.aequuspharma.ca |
| Phone | 604 336 7906 |
| Currency | USD - US Dollar |
Aequus Pharmaceuticals Key Financial Ratios
There are many critical financial ratios that Aequus Pharmaceuticals' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Aequus Pharmaceuticals reports annually and quarterly.| Return On Equity | -2.92 | |||
| Return On Asset | -0.42 | |||
| Number Of Employees | 14 | |||
| Beta | 0.44 | |||
| Z Score | 93.4 |
Aequus Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Aequus Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Aequus Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Aequus Pharmaceuticals competition to find correlations between indicators driving Aequus Pharmaceuticals's intrinsic value. More Info.Aequus Pharmaceuticals is rated second in return on equity category among its peers. It is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Aequus Pharmaceuticals' earnings, one of the primary drivers of an investment's value.Aequus Pharmaceuticals Systematic Risk
Aequus Pharmaceuticals' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Aequus Pharmaceuticals volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty with a total number of output elements of thirty-one. The Beta measures systematic risk based on how returns on Aequus Pharmaceuticals correlated with the market. If Beta is less than 0 Aequus Pharmaceuticals generally moves in the opposite direction as compared to the market. If Aequus Pharmaceuticals Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Aequus Pharmaceuticals is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Aequus Pharmaceuticals is generally in the same direction as the market. If Beta > 1 Aequus Pharmaceuticals moves generally in the same direction as, but more than the movement of the benchmark.
Aequus Pharmaceuticals December 15, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Aequus Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Aequus Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Aequus Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Aequus OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Aequus Pharmaceuticals's daily price indicators and compare them against related drivers.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 54.76 | |||
| Value At Risk | (11.36) | |||
| Potential Upside | 7.84 |
Complementary Tools for Aequus OTC Stock analysis
When running Aequus Pharmaceuticals' price analysis, check to measure Aequus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aequus Pharmaceuticals is operating at the current time. Most of Aequus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Aequus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aequus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Aequus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |